blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2452648

EP2452648 - System for selectable eccentric remodeling and/or ablation of atherosclerotic material [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  07.12.2018
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  21.08.2018
Most recent event   Tooltip07.12.2018Revocation of patentpublished on 09.01.2019  [2019/02]
Applicant(s)For all designated states
Vessix Vascular, Inc.
26052 Merit Circle, Suite 106
Laguna Hills, CA 92653 / US
[2016/06]
Former [2012/20]For all designated states
Vessix Vascular, Inc.
26052 Merit Circle, Suite 106
Laguna Hills, CA 92653 / US
Inventor(s)01 / Steinke, Tom, A.
P.O. Box 910326
San Diego, CA California 92191 / US
02 / Stone, Corbett, W.
P.O. Box 910326
San Diego, CA California 92191 / US
03 / Ross, Stephen, O.
P.O. Box 910326
San Diego, CA California 92191 / US
04 / Kelleher, Brian, S.
P.O. Box 910326
San Diego, CA California 92191 / US
05 / Michel, Raphael, M.
P.O. Box 910326
San Diego, CA California 92191 / US
 [2012/20]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2016/06]
Former [2013/09]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Former [2013/08]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Former [2012/20]Clark, Jane Anne
Mathys & Squire LLP 120 Holborn
London EC1N 2SQ / GB
Application number, filing date12151957.310.09.2004
[2012/20]
Priority number, dateUS20030502515P12.09.2003         Original published format: US 502515 P
[2012/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2452648
Date:16.05.2012
Language:EN
[2012/20]
Type: B1 Patent specification 
No.:EP2452648
Date:10.02.2016
Language:EN
[2016/06]
Search report(s)(Supplementary) European search report - dispatched on:EP16.04.2012
ClassificationIPC:A61B18/18
[2012/20]
CPC:
A61B18/1492 (EP,US); A61B18/18 (EP,US); A61B18/1815 (EP,US);
A61B2018/0016 (EP,US); A61B2018/00214 (EP,US); A61B2018/0022 (EP,US);
A61B2018/00267 (EP,US); A61B2018/0041 (EP,US); A61B2018/00577 (US);
A61B2018/00601 (US); A61B2018/00654 (EP,US); A61B2018/1861 (EP,US);
A61B2090/373 (EP,US); A61B2090/374 (EP,US); A61B2090/376 (EP,US);
A61B2090/3784 (EP,US); A61B2218/002 (EP,US); A61B2218/007 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/06]
Former [2012/20]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:System zur auswählbaren exzentrischen Umformung bzw. Ablation von atherosklerotischem Material[2012/20]
English:System for selectable eccentric remodeling and/or ablation of atherosclerotic material[2012/20]
French:Système de remodelage et/ou de l'ablation excentrique sélectionnable de matériau athérosclérotique[2012/20]
Examination procedure16.11.2012Amendment by applicant (claims and/or description)
16.11.2012Examination requested  [2012/52]
05.02.2013Despatch of a communication from the examining division (Time limit: M04)
17.06.2013Reply to a communication from the examining division
19.11.2014Despatch of a communication from the examining division (Time limit: M04)
27.03.2015Reply to a communication from the examining division
22.07.2015Communication of intention to grant the patent
27.11.2015Fee for grant paid
27.11.2015Fee for publishing/printing paid
27.11.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP04816863.7  / EP1667595
Divisional application(s)EP16154519.9  / EP3045136
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040816863) is  22.01.2010
Opposition(s)Opponent(s)01  10.02.2016  24.02.2016  ADMISSIBLE
Medtronic Ardian Luxembourg S.à.r.l. / Medtronic Vascular Galway Unlimited Company
102, rue des Maraîchers /
Parkmore Business Park West, Ballybrit
2124 Luxembourg / Galway, IE / LU
Opponent's representative
Bandpay & Greuter, et al, et al
11 rue Christophe Colomb
75008 Paris / FR
 [N/P]
Former [2016/13]
Opponent(s)01  10.02.2016  24.02.2016  ADMISSIBLE
Medtronic Ardian Luxembourg S.à.r.l. / Medtronic Vascular Galway
102, rue des Maraîchers /
Parkmore Business Park West, Ballybrit
2124 Luxembourg / Galway, IE / LU
Opponent's representative
Bandpay & Greuter, et al, et al
30, rue Notre-Dame des Victoires
75002 Paris / FR
19.12.2016Invitation to proprietor to file observations on the notice of opposition
27.04.2017Reply of patent proprietor to notice(s) of opposition
28.06.2018Date of oral proceedings
28.06.2018Legal effect of revocation of patent [2019/02]
22.08.2018Despatch of minutes of oral proceedings
22.08.2018Despatch of communication that the patent will be revoked
Fees paidRenewal fee
20.01.2012Renewal fee patent year 03
20.01.2012Renewal fee patent year 04
20.01.2012Renewal fee patent year 05
20.01.2012Renewal fee patent year 06
20.01.2012Renewal fee patent year 07
20.01.2012Renewal fee patent year 08
12.09.2012Renewal fee patent year 09
12.09.2013Renewal fee patent year 10
12.09.2014Renewal fee patent year 11
11.09.2015Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.09.2004
AT10.02.2016
BE10.02.2016
CY10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
MC10.02.2016
PL10.02.2016
RO10.02.2016
SI10.02.2016
SK10.02.2016
TR10.02.2016
BG10.05.2016
GR11.05.2016
PT13.06.2016
LU10.09.2016
[2018/29]
Former [2018/28]HU10.09.2004
AT10.02.2016
BE10.02.2016
CY10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
MC10.02.2016
PL10.02.2016
RO10.02.2016
SI10.02.2016
SK10.02.2016
BG10.05.2016
GR11.05.2016
PT13.06.2016
LU10.09.2016
Former [2017/47]AT10.02.2016
BE10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
MC10.02.2016
PL10.02.2016
RO10.02.2016
SI10.02.2016
SK10.02.2016
BG10.05.2016
GR11.05.2016
PT13.06.2016
LU10.09.2016
Former [2017/31]AT10.02.2016
BE10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
MC10.02.2016
PL10.02.2016
RO10.02.2016
SI10.02.2016
SK10.02.2016
BG10.05.2016
GR11.05.2016
PT13.06.2016
Former [2017/15]AT10.02.2016
BE10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
PL10.02.2016
RO10.02.2016
SI10.02.2016
SK10.02.2016
BG10.05.2016
GR11.05.2016
PT13.06.2016
Former [2017/03]AT10.02.2016
BE10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
PL10.02.2016
RO10.02.2016
SK10.02.2016
GR11.05.2016
PT13.06.2016
Former [2016/50]AT10.02.2016
CZ10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
PL10.02.2016
RO10.02.2016
SK10.02.2016
GR11.05.2016
PT13.06.2016
Former [2016/49]AT10.02.2016
DK10.02.2016
EE10.02.2016
FI10.02.2016
PL10.02.2016
GR11.05.2016
PT13.06.2016
Former [2016/46]AT10.02.2016
DK10.02.2016
FI10.02.2016
PL10.02.2016
GR11.05.2016
PT13.06.2016
Former [2016/38]AT10.02.2016
FI10.02.2016
PL10.02.2016
GR11.05.2016
PT13.06.2016
Former [2016/36]AT10.02.2016
FI10.02.2016
PL10.02.2016
GR11.05.2016
Former [2016/35]FI10.02.2016
GR11.05.2016
Documents cited:Search[XI]US5848969  (PANESCU DORIN [US], et al) [X] 1-4,7,8,16-18 * column 6, line 60 - column 8, line 31; figures 14,15,23,24 * * column 12, lines 57-59 * * column 14, lines 39-40 * [I] 9-11;
 [XI]WO9900060  (ADVANCED CORONARY INTERVENTION [US]) [X] 1-4,7,8,17 * page 25, lines 9-30; figures 7,12,14,20; claim 1 * * page 15, lines 22-31 * * page 10, lines 3-8 *[I] 9-11;
 [XI]WO02087679  (BARD INC C R [US], et al) [X] 1,2,4-8,12-15,17-19 * page 6, lines 9-11 * * page 13, line 27 - page 15, line 9; figures 8,10,18,20A-E * * page 27, lines 9-13; figures 1,6,6A,18,24 * * page 12, lines 5-12 * [I] 3,9-11,16;
 [X]WO02089686  (RITA MEDICAL SYSTEMS INC [US]) [X] 1,4-7,10-19 * page 8, line 23 - page 14, line 3 * * page 28, lines 12-28 * * page 42, line 5 - page 43, line 17; figures 12,26 * * page 35, lines 19-22 * * page 21, lines 15-19 * * page 15, lines 5-7 *
ExaminationUS5722401
 US5755760
 WO0137723
 US6322559
    - Ru San Tan ET AL, "Power Versus Temperature-Controlled Ablation of Supraventricular Tachycardia", Asian Cardiovasc Thorac Ann, (20010101), vol. 9, pages 115 - 118, XP055051048

DOI:   http://dx.doi.org/10.1177/021849230100900211
by applicantUS4682596
 US5098431
 US5454809
 US5749914
 US6582423
    - SLAGER ET AL., "Vapori-7ation ofAtherosclerotic Plaque by Spark Erosion", J. OF AMER. CARDIOL., (198506), pages 1382 - 6
OppositionUS5279299
 US5454370
 US5487385
 WO9717892
 WO9812999
 US5882333
 US6004269
 WO0001313
 US6325797
 US6356790
 US2002139379
 WO02087679
 US2002165532
 WO02087676
 US6542781
 US6702811
 US6711444
 US2004167509
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.